MESO Mesoblast Limited

7.90
-0.73  -8%
Previous Close 8.63
Open 8.37
Price To book 1.29
Market Cap 601.14M
Shares 76,094,000
Volume 88,883
Short Ratio 11.79
Av. Daily Volume 41,392

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Ongoing
MPC-06-ID
Chronic low back pain
Phase 3 data due 2H 2017.
MSC-100-IV
acute graft versus host disease (aGVHD) in children
Phase 2 data released August 2016. Partnership required for Phase 3 development.
MPC-300-IV
Rheumatoid arthritis
Noted April 10, 2017 that interim analysis has been completed - trial to continue as planned.
MPC-150-IM
Chronic heart failure (CHF)